bStocks' Tokenized Shares Surpass $1 Billion in Assets Under Management in Four Months

bStocks' tokenized shares have surpassed $1 billion in assets under management as of October 15, 2026, approximately four months after their launch on June 11.

Key Points

• bStocks covers nearly 100 tickers, up from five at launch.
• A significant portion of trading occurs outside regular U.S. stock market hours.
• On-chain lending and transfers have grown alongside assets under management.

This milestone comes alongside over $6 billion in conversions between the tokens and the underlying shares. Most trading also takes place outside regular market hours in the U.S.

Binance stated in a blog post that the product accounts for about a quarter of the market capitalization of the tokenized stock sector as of October. A separate statement, citing data from Dune Research as of October 15, describes bStocks as the fastest tokenized stock product to reach $1 billion in assets under management.

From Five to Nearly 100 Tickers: The Growth of bStocks Tokenized Shares

The bStocks listing has grown from five tickers in June to nearly 100 four months later. This includes infrastructure for artificial intelligence, semiconductors, and sector ETFs.

The tokens provide 1:1 exposure to a selection of U.S.-listed stocks and ETFs. According to the statement, each token is fully backed by the underlying security, settles on-chain, and can move between accounts on the exchange and self-custody wallets.

The cumulative trading volume has exceeded $40 billion since June 11, averaging over $300 million per day, the statement also reports. This figure is distinct from both assets under management and conversions into directly held shares.

Commission-Free Conversions and 24/7 Trading

Those who own bStocks can exchange them for the corresponding shares at par, 1:1, and without conversion fees. The redemption delivers the underlying security, not just its cash equivalent, and the two formats coexist in the same account on the exchange.

By October, users had already converted over $6 billion between the two formats. According to the statement, the operation does not require a transfer between brokers or waiting for the markets to open.

The product trades 24/7, including weekends. A Binance Research study indicates that only 42% of August's volume was concentrated in regular U.S. sessions, compared to 89.2% for traditional U.S. stocks.

The remaining 58% was distributed among pre-market, after-hours, overnight, and weekend trading. A separate July survey indicated a share of 38% for regular sessions.

Usage does not stop at trading. At the beginning of October, bStocks reached an 11.2% utilization rate in decentralized finance, measured by the total value locked, about 3.8 percentage points above comparable tokenized stocks, according to the research.

bStocks Collateralized Loans: From 5.5% to 46.2%

The share of bStocks deposited as collateral and used for borrowing rose from 5.5% at the end of June to 46.2% on September 10, 2026. About $3.1 million had been borrowed against $6.8 million in collateral.

In September, the exchange extended collateral support to all eligible users. Supported tokens can serve as margin and collateral for futures, allowing for borrowing of listing assets and gaining exposure with leverage up to 5x, or using the same token as collateral and as a hedge on futures.

Significant Increase in Transfers and ADGM Supply Constraints

On-chain transfers of tokenized shares, including trading volume, surpassed $100 billion in the third quarter of 2026, according to Binance Research. This is more than 16 times the $6 billion in the first quarter.

bStocks has driven much of the growth, reaching over 90% of the weekly transfer volume at the peak in early August. The research indicates tokenized shares as the fastest-growing category of real-world assets in 2026: the market capitalization has risen by 390.4% since the beginning of the year and exceeded $3 billion by the end of September.

The securities are offered through an Approved Prospectus in ADGM, only in the secondary market and for eligible users in permitted jurisdictions. There is no public offering outside of ADGM, and the product is not available in the United States or to U.S. persons.